NO873885L - Fremgangsmaate ved fremstilling av terapeutisk aktive lipaser og lipaseekstrakter. - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk aktive lipaser og lipaseekstrakter.

Info

Publication number
NO873885L
NO873885L NO873885A NO873885A NO873885L NO 873885 L NO873885 L NO 873885L NO 873885 A NO873885 A NO 873885A NO 873885 A NO873885 A NO 873885A NO 873885 L NO873885 L NO 873885L
Authority
NO
Norway
Prior art keywords
lipase
procedure
preparation
therapeutic active
active lipases
Prior art date
Application number
NO873885A
Other languages
English (en)
Other versions
NO170316B (no
NO170316C (no
NO873885D0 (no
Inventor
Herve Moreau
Robert Verger
Daniel Lecat
Jean-Louis Junien
Original Assignee
Jouveinal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal Sa filed Critical Jouveinal Sa
Publication of NO873885D0 publication Critical patent/NO873885D0/no
Publication of NO873885L publication Critical patent/NO873885L/no
Publication of NO170316B publication Critical patent/NO170316B/no
Publication of NO170316C publication Critical patent/NO170316C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
NO873885A 1986-09-17 1987-09-16 Fremgangsmaate ved fremstilling av en lipaseekstrakt elleren lipase NO170316C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8612996A FR2603804B1 (fr) 1986-09-17 1986-09-17 Lipases et extraits lipasiques, leur procede de preparation et leur application en therapeutique

Publications (4)

Publication Number Publication Date
NO873885D0 NO873885D0 (no) 1987-09-16
NO873885L true NO873885L (no) 1988-03-18
NO170316B NO170316B (no) 1992-06-29
NO170316C NO170316C (no) 1992-10-07

Family

ID=9339032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873885A NO170316C (no) 1986-09-17 1987-09-16 Fremgangsmaate ved fremstilling av en lipaseekstrakt elleren lipase

Country Status (17)

Country Link
US (1) US5075231A (no)
EP (1) EP0261016B1 (no)
JP (1) JPS6379589A (no)
KR (1) KR960011522B1 (no)
AT (1) ATE86661T1 (no)
AU (1) AU602349B2 (no)
CA (1) CA1308678C (no)
DE (1) DE3784607T2 (no)
DK (1) DK483087A (no)
ES (1) ES2053575T3 (no)
FI (1) FI87232C (no)
FR (1) FR2603804B1 (no)
IE (1) IE59972B1 (no)
IS (1) IS3251A7 (no)
NO (1) NO170316C (no)
NZ (1) NZ221568A (no)
ZA (1) ZA876322B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683549B1 (fr) * 1991-11-13 1994-11-18 Jouveinal Inst Rech Acides nucleiques codant pour la lipase gastrique de lapin et derives polypeptidiques, leur utilisation pour la production de ces polypeptides, et compositions pharmaceutiques a base de ces derniers.
US5998189A (en) * 1992-12-16 1999-12-07 Warner-Lambert Company Polypeptide derivatives of dog gastric lipase and pharmaceutical compositions containing same
FR2699179B1 (fr) * 1992-12-16 1995-01-06 Jouveinal Inst Rech Acides nucléiques codant pour la lipase gastrique de chien et dérivés polypeptidiques, leur utilisation pour la production de ces polypeptides, et compositions pharmaceutiques à base de ces derniers.
FR2733249B1 (fr) 1995-04-20 1997-06-06 Biocem Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
US6642038B1 (en) 1999-09-14 2003-11-04 Genzyme Glycobiology Research Institute, Inc. GlcNAc phosphotransferase of the lysosomal targeting pathway
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
WO2001049282A2 (en) * 2000-01-06 2001-07-12 Martek Biosciences Corporation Therapeutic preparations of highly unsaturated fatty acids
EP1149585A1 (en) * 2000-04-27 2001-10-31 Warner-Lambert Company Use of recombinant gastric lipase for treating functional dyspepsia
US6905856B2 (en) 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US6800472B2 (en) 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
DE102005010604B3 (de) * 2005-03-06 2006-07-20 Lange Uhren Gmbh Uhr
KR100828146B1 (ko) * 2006-04-28 2008-05-08 김우식 췌장 리파아제의 선택적 추출방법
EP1870649A1 (en) 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
US8221747B2 (en) 2007-02-20 2012-07-17 Aptalis Pharma Limited Stable pancreatic enzyme compositions
WO2009052182A1 (en) 2007-10-15 2009-04-23 Jbs United, Inc. Method for increasing performance of offspring
CL2011002432A1 (es) 2010-10-01 2012-04-20 Aptalis Pharma Ltd Composicion que comprende al menos una enzima digestiva y al menos un portador, en donde el portador comprende celulosa microcristalina que tiene un tamaño de particulas mayor que 100 um; una forma de dosificacion; el envase que la contiene; un proceso para preparar la composicion; y sus usos.
KR101953413B1 (ko) 2011-08-08 2019-02-28 앨러간 파마슈티컬스 인터내셔널 리미티드 소화효소들을 함유하는 고형 조성물들의 용해 시험 방법
KR20160087794A (ko) 2013-08-09 2016-07-22 앨러간 파마슈티컬스 인터내셔널 리미티드 장관 투여에 적합한 소화 효소 조성물
CA2915671A1 (en) * 2013-11-05 2015-05-14 Aptalis Pharma Ltd. High potency pancreatin pharmaceutical compositions
EP3157568A1 (en) 2014-06-19 2017-04-26 Aptalis Pharma Limited Methods for removing viral contaminants from pancreatic extracts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3256150A (en) * 1964-04-20 1966-06-14 Dairyland Food Lab Method for treating malabsorption syndrome
GB1139991A (en) * 1965-07-19 1969-01-15 Armour Pharma Stabilized enzyme composition
FR6622M (no) * 1967-09-12 1969-01-13
WO1985000381A1 (en) * 1983-07-01 1985-01-31 Celltech Limited Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production
GB8421210D0 (en) * 1984-08-21 1984-09-26 Celltech Ltd Polypeptide and polypeptide composition

Also Published As

Publication number Publication date
NO170316B (no) 1992-06-29
DK483087D0 (da) 1987-09-15
FR2603804B1 (fr) 1989-10-27
CA1308678C (en) 1992-10-13
KR960011522B1 (ko) 1996-08-23
NO170316C (no) 1992-10-07
AU7795687A (en) 1988-03-24
FR2603804A1 (fr) 1988-03-18
DK483087A (da) 1988-03-18
KR880004084A (ko) 1988-06-01
ES2053575T3 (es) 1994-08-01
JPS6379589A (ja) 1988-04-09
DE3784607D1 (de) 1993-04-15
IS3251A7 (is) 1987-11-30
FI874038A (fi) 1988-03-18
AU602349B2 (en) 1990-10-11
FI874038A0 (fi) 1987-09-16
EP0261016A1 (fr) 1988-03-23
EP0261016B1 (fr) 1993-03-10
IE59972B1 (en) 1994-05-04
FI87232B (fi) 1992-08-31
FI87232C (fi) 1992-12-10
US5075231A (en) 1991-12-24
NO873885D0 (no) 1987-09-16
ZA876322B (en) 1988-03-02
ATE86661T1 (de) 1993-03-15
DE3784607T2 (de) 1993-10-07
IE872401L (en) 1988-03-17
NZ221568A (en) 1991-11-26

Similar Documents

Publication Publication Date Title
NO873885D0 (no) Fremgangsmaate ved fremstilling av terapeutisk aktive lipaser og lipaseekstrakter.
DK396381A (da) Faste laegemiddelpraeparater og fremgangsmaade til deres fremstilling
MC1811A1 (fr) Extrait de plantes de l'espece nerium procede pour sa preparation et ses applications
NO823674L (no) Derivater av cis, endo-2-azabicyklo-(3.3.0)-oktan-3-3-karboksylsyrer, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse
ES508378A0 (es) Un metodo para la preparacion de un extracto de proteinas vegetales.
IL73034A (en) Pharmaceutical composition containing refined detoxified endotoxin and a pyridine-soluble extract of a microorganism
NZ224295A (en) A method of producing native or physiologically active secondary structure in physiologically inactive proteins
YU147485A (en) Process for obtaining stable camomile extract containing high percent of active substances
DE3268160D1 (en) Medicaments based on algae, and formulations thereof
ES548889A0 (es) Un procedimiento para preparar una vacuna anti-helmintica que comprende una suspension, homogeneizado o extracto de una especie de nematodo y un vehiculo farmaceutico.
FR2584726B1 (fr) Ilexosides, extraits d'ilex mitis, procede d'extraction et compositions pharmaceutiques et cosmetiques comportant des ilexosides
BR6501950U (pt) Sistema para producao de extrato de soja
NO883674D0 (no) 5-hydroksy-3-aminokroman-forbindelser, fremgangsmaater for deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelsene og metoder for behandling dermed.
BR6700532U (pt) Sistema contra assaltos comuns
NO163895C (no) Derivater av cis, endo-2-azabiscyklo-(3.3.0)-oktan-3-karboksylsyre og fremgangsmaate til deres fremstilling.
NO872687D0 (no) Superkritisk fluidekstrahering av animalavledende stoffer.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees